ダウンロード数: 140
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
25_1211.pdf | 277.24 kB | Adobe PDF | 見る/開く |
タイトル: | 膀胱腫瘍に対するET-207膀胱内注入療法 |
その他のタイトル: | INTRAVESICAL TREATMENT OF BLADDER TUMOR WITH FT207 |
著者: | 上田, 正山 谷野, 誠 |
著者名の別形: | Ueda, Masataka Tanino, Makoto |
発行日: | Nov-1979 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 25 |
号: | 11 |
開始ページ: | 1211 |
終了ページ: | 1215 |
抄録: | We instilled FT 207 (N/-(12-tetra-hydrouracil-5-fluorouracil) 2000-4000 mg (20-40 ml) intravesically in 24 cases of bladder tumor twice a week for a total of 10 instillations. The anti-tumor effect of this preparation was studied in 6 cases which were treated for the first time. As a result, there were temporary clearance of tumor in 1 case, regression in 2 cases, and 1 unchanged case, but in no case was complete clearance observed. As to the effect to prevent recurrence, recurrence was noted in 8 out of 16 cases with intravesical instillation)of FT 207 alone and 6 out of8 cases with combinational use of [60]Co irradiation of the bladder and pelvic region and intravesical instillation of FT 207 during a 23-month observation. Irritative symptoms, of the bladder leukopenia and other side-effects were not observed during the period of of intravesical instillation. The anti-tumor effect and recurrence-preventing effect of intravesical instillation of FT 207 appear to be lower than those of other anti-cancer drugs. However, it should be noted that the lymph node levels of FT 207, when instilled intravesically, are higher than those of other anti-cancer drugs. If the method of administration is studied durther, this preparation is expected to exert effect on infiltrative tumor. |
URI: | http://hdl.handle.net/2433/122530 |
出現コレクション: | Vol.25 No.11 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。